YSP Southeast Asia Holding Bhd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares YSP Southeast Asia Holding Bhd with three other
pharmaceutical manufacturers in Asia:
Anuh Pharma Limited
sales of 3.26 billion Indian Rupees [US$49.85 million]
Lanzhou Foci Pharmaceutical Co Limited
(363.22 million Chinese Renmimbi [US$52.77 million]
of which 99%
was Pharmacies), and
Highnoon Laboratories Limited
based in Pakistan
(5.07 billion Pakistan Rupees [US$48.43 million]
YSP Southeast Asia Holding Bhd reported sales of 237.07 million Malaysian Ringgits (US$53.54 million)
December of 2016.
increase of 6.3%
versus 2015, when the company's sales were 222.93 million Malaysian Ringgits.
Sales at YSP Southeast Asia Holding Bhd have increased during each of the previous five years
(and since 2011, sales have increased a total of 51%).